- “Breakthrough Neo Elite laser technology demonstrated significant visible improvement in psoriasis lesions after a single session.”
- The treatment demonstrated effectiveness on chronic and difficult-to-treat plaques.
- The patient’s clinical improvement was accompanied by reported benefits in comfort and well-being.
- The case highlights the emerging role of laser technology in psoriasis management in India.
New Delhi: 31st Dec’25: Psoriasis patients struggling with stubborn plaques and chronic inflammation may now have a powerful new non-pharmaceutical treatment option. In a recent clinical case, Aerolase Neo Elite, an advanced 1064 nm Nd:YAG laser platform, demonstrated dramatic visible clearance in just one session, redefining expectations in psoriasis management.
The case was reported by Dr. Rashmi Agrawal, Founder and Medical Director of SKIN – Skin International Aesthetic Laser Clinic, involving a young male patient with psoriasis who had inconsistent topical medication use but maintained regular moisturization. Despite the chronic nature of his condition and involvement of difficult-to-treat areas, the response to a single Neo Elite session was described as “mind-boggling.”
Unlike conventional therapies that often rely on long-term medications or systemic agents, the Aerolase Neo Elite targets inflammation at its root using break -through 650 micro sec technology 1064 nm Nd:YAG laser, without causing skin injury or systemic side effects. Even thick, inflamed plaques responded exceptionally well, highlighting the laser’s ability to deliver powerful results while remaining gentle on the skin.
Psoriasis affects over 125 million people worldwide, with an estimated 2–3% of India’s population—nearly 30 million individuals—living with this chronic condition. Frequently dismissed as a cosmetic concern, psoriasis has a profound impact on mental health, self-esteem, and quality of life. Increased awareness of advanced, non-invasive treatment options can play a critical role in early intervention, stigma reduction, and improved patient outcomes.
Commenting on the case, Dr. Rashmi Agrawal said:
“The results were truly mind-boggling. Aerolase Neo Elite has completely changed how I look at psoriasis management. This non-invasive, no-downtime treatment targets inflammation at its root using the break -through 650 micro sec technology 1064 nm Nd:YAG . It offers a safer, comfortable, and effective—even for challenging cases. New innovative cutting-edge technologies like Neo Elite are elevating the standard of care and allowing us to deliver faster, safer, and more patient-friendly solutions.”
Neo Elite from Aerolase, an US multinational, is designed to deliver high energy through its proprietary 650-microsecond pulse duration, enabling effective treatment of inflammatory skin conditions while maintaining exceptional patient comfort. Dermatologists can safely treat sensitive and hard-to-reach areas, often with visible improvement from the very first session. With no downtime and no systemic exposure, the technology integrates seamlessly alongside existing treatment protocols.
Psoriasis requires sustained management and a comprehensive care approach to achieve long-term improvement. Advanced modalities such as Neo Elite can contribute to a significant reduction in psoriatic lesions, improvement in skin texture, and overall skin health when used as part of a structured treatment plan. Consistent maintenance, including appropriate moisturisation and follow-up care, is essential to optimise outcomes and support skin barrier function. By combining effective treatment with ongoing skin care, patients can experience not only visible clinical improvement but also enhanced comfort and confidence. Such integrated approaches underscore the importance of addressing both the physical manifestations of psoriasis and its broader impact on patient well-being.
“We are thrilled to see Neo Elite transforming real-world psoriasis care in India,” said Madhusudan HK, Country Head, Aerolase India.
“Dr. Agrawal’s case powerfully validates what makes Neo Elite different—its ability to deliver high-powered clinical outcomes gently and safely across all skin types. This is just the beginning of how Neo Elite will help raise dermatology standards and expand access to advanced care nationwide.”
As demonstrated by this breakthrough case, Aerolase Neo Elite represents a significant step forward in patient-centered psoriasis care. With its ability to integrate into diverse treatment approaches, this innovation holds promise for improving the quality of life for millions living with psoriasis in India and beyond.
Patient Perspective
For the patient, psoriasis was not just a skin condition—it carried an emotional burden that quietly shaped daily life. Visible plaques and persistent itching led to social withdrawal, embarrassment, and constant self-monitoring. “People would stare or ask uncomfortable questions, and over time you start feeling judged,” he shared. “It affects your confidence and your mental peace in ways most people don’t see.”
Following the Neo Elite session, the relief extended far beyond the skin. “As the redness and itching reduced, I felt lighter emotionally. I stopped worrying about hiding affected areas or explaining my condition. For the first time in years, I felt normal again.” The improvement, he says, restored not just comfort, but dignity—highlighting how effective, patient-friendly treatments can help reduce stigma and support mental well-being alongside physical recovery.
About Aerolase
Aerolase, a U.S.-based innovator in medical laser technology, is gaining global attention for its breakthrough approach to dermatological treatment. The company’s flagship platform, Neo Elite, powered by a proprietary 650-microsecond pulse duration, is delivering strong clinical outcomes across a wide range of skin conditions with minimal discomfort and no downtime. Designed for safe use on all skin types, Aerolase laser systems are now trusted by dermatologists and aesthetic practitioners in more than 50 countries, reinforcing the company’s growing impact on modern, patient-centric dermatology.
Discussion about this post